SSX2 and synovial sarcoma: The SYT-SSX2 fusion protein present in one-third of synovial sarcomas (SS) interacts with components of the Polycomb repressive and SWI/SNF chromatin-remodeling complexes, which leads to global alteration of nuclear programming and tumor initiation [24].